Navigation Links
Bedford Laboratories(TM) To Begin Shipping Fluconazole Injection
Date:1/14/2010

BEDFORD, Ohio, Jan. 14 /PRNewswire/ -- Bedford Laboratories™, a division of Ben Venue Laboratories, Inc., is pleased to announce FDA approval for the addition of 100 mg/50 mL Fluconazole Injection to its existing Fluconazole Injection line. This product is AP rated and is equivalent to Diflucan® by Pfizer. Fluconazole Injection is an antifungal agent indicated for oropharyngeal and esophageal candidiasis, cryptococcal meningitis, and is indicated for the prophylaxis of candidiasis.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070809/CLTH157LOGO )

"Pharmacists asked, we answered. In our continuing effort to offer the most comprehensive and cost effective line of injectables in the multisource industry, Bedford Laboratories is pleased to be the first to offer this unique dosage. Fluconazole Injection 100 mg/50 mL is right-sized for smaller doses, speeding productivity and saving time. This continues to demonstrate our commitment to providing a broad-based portfolio of products," said David Gaugh, Vice President of Bedford Laboratories.

Bedford Laboratories will supply Fluconazole Injection sterile iso-osmotic solution containing 2 mg/mL of fluconazole in glass vials in the following presentations:  Vials containing either 100 mg, 200 mg or 400 mg equivalent of fluconazole. In addition, Bedford Laboratories will supply Fluconazole Injection as a sterile iso-osmotic solution containing 2 mg / mL of fluconazole in 0.9% sodium chloride diluent in the following presentations:  200 mg/100 mL in single-dose PVC flexible containers packaged in cartons con
'/>"/>

SOURCE Bedford Laboratories
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
2. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
3. Enrollment Begins on Human PK Study for Medidur(TM) FA
4. Vical Begins Phase 1 Trial of DNA Vaccine Against H5N1 Pandemic Influenza
5. Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
6. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
7. Metabolex Begins Phase 2 Trial of MBX-8025 for Treatment of Dyslipidemia
8. DiObex Begins Dosing Patients in Phase 2b Trial of Type 2 Diabetes Drug
9. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
10. Dynavax Begins TOLAMBA(TM) Environmental Exposure Chamber Study
11. BiPar Begins Phase 2 Study of Lead PARP Inhibitor in Triple-Negative Breast Cancer Based on Overexpression Biomarker Data
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... , April 21, 2015 ... for Enterprise, having more than doubled its overseas sales ... PharmaGenesis today celebrates winning the Queen,s Award for Enterprise, ... is the world,s first HealthScience Communications consultancy, helping its ... of patient need. Having more than doubled its exports ...
(Date:4/21/2015)... Cardiologists at Henry Ford Hospital have implanted a device that ... heartbeat. With only handful of hospitals in the ... to add another option to its arsenal of tools for ... to pump. "This is a first in ... at a non-clinical trial site," says cardiologist Claudio Schuger ...
(Date:4/21/2015)... , April 21, 2015  St. Vincent ... to patient care. Already following strict disinfection routines, ... Tru-D SmartUVC to eliminate harmful germs, like Ebola, ... and norovirus that can infect patients during their ... Logo - http://photos.prnewswire.com/prnh/20150420/199749LOGO ...
Breaking Medicine Technology:Queen's Award Crowns Achievements of Local Consultancy 2Queen's Award Crowns Achievements of Local Consultancy 3Queen's Award Crowns Achievements of Local Consultancy 4Queen's Award Crowns Achievements of Local Consultancy 5Stroke Risk Caused by Abnormal Heart Rhythm Reduced Without Blood Thinners 2Stroke Risk Caused by Abnormal Heart Rhythm Reduced Without Blood Thinners 3St. Vincent Healthcare Deploys Germ-Killing Robot to Prevent Infection, Protect Patients During Hospital Visits 2St. Vincent Healthcare Deploys Germ-Killing Robot to Prevent Infection, Protect Patients During Hospital Visits 3
... NEW YORK, April 14, 2011 Dr. David Samadi, Vice ... at The Mount Sinai Medical Center in New York City , ... month in the British Medical Journal ( ... 1,500 of whom were screened for prostate cancer every ...
... Calif., April 14, 2011 Freedom Innovations, a ... technology lower extremity prosthetic devices, today announced a ... exclusive rights to commercialize the world,s first lower ... joints that operate synergistically.  Developed at the Vanderbilt ...
Cached Medicine Technology:Does Prostate Cancer Screening Reduce Mortality Rates? 2Does Prostate Cancer Screening Reduce Mortality Rates? 3Does Prostate Cancer Screening Reduce Mortality Rates? 4Freedom Innovations to Commercialize the World's First Actively-Powered, Complete Lower Extremity Prosthesis 2Freedom Innovations to Commercialize the World's First Actively-Powered, Complete Lower Extremity Prosthesis 3
(Date:4/21/2015)... 2015 AvePoint, the established ... today announced a new enhancement to DocAve Policy ... Office 365 Management Activity API. This integration creates a ... and take action on all events that take place ... 365 Management Activity API provides customers with greater transparency ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 Wireless ... services, has been recognized by the Boston Business Journal ... The ranking was announced at a recent event celebrating ... list of the fastest-growing private companies in Massachusetts. , ... in the state that recorded the fastest revenue growth ...
(Date:4/21/2015)... April 21, 2015 Lowcostcarinsuranceprice.com has released a ... auto insurance for SUVs. , SUVs are large ... collision between an SUV and a smaller regular car shows ... of surviving. This makes SUV safer in crashes, but these ... in certain situation. , It is now possible to ...
(Date:4/21/2015)... The report “Dermatitis – ... on the therapeutic development for Dermatitis. ... new targets and MOAs to produce first-in-class ... is available @ http://www.rnrmarketresearch.com/dermatitis-pipeline-review-h1-2015-market-report.html . ... involved in the therapeutic development for Dermatitis ...
(Date:4/21/2015)... has released a new blog post presenting heavily circulated ... insurance prices . , Commuting on heavy circulated ... their insurance options before deciding what plan to buy. ... of the popular policies provide liability, collision or comprehensive ... find the best prices in their area simply by ...
Breaking Medicine News(10 mins):Health News:AvePoint Integrates Microsoft Office 365 Management Activity API into DocAve Policy Enforcer for Proactive SharePoint Monitoring 2Health News:AvePoint Integrates Microsoft Office 365 Management Activity API into DocAve Policy Enforcer for Proactive SharePoint Monitoring 3Health News:Wireless Analytics Ranked as 25th Fastest Growing Private Company in Massachusetts 2Health News:Auto Insurance Quotes For SUVs Are Available Online 2Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 2Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 3Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 4Health News:Heavily Circulated Roads Can increase Auto Insurance Costs 2
... hair loss in people as young as 16 whereas the phenomenon ... ,"Nobody can escape stress in modern day life. Stress ... the thinning of hair," Mumbai-based Sonal Shah said. ,"Initially, ... has come down to as low as 16 and 18," Shah ...
... State University are pumping for a controversial theory, which ... into "dark states" where they can be easily dismantled ... some of the most accepted theories in biochemistry. ... by much of the science community, has just in ...
... to reconstruct a complex molecular system of Darwinian evolution for ... genes. ,The research was led by ... Oregon's Center for Ecology and Evolutionary Biology, and will be ... selection can drive the evolution of complex molecular systems – ...
... a study conducted by the University of Erfurt in ... to inflict financial pain to achieve// collective gain. The ... ,Researchers have found that groups in which ... more popular than groups without this option. Though two ...
... at a high risk for developing Alzheimer's disease would benefit ... ibuprofen. This therapy appears to be of maximum benefit in ... is a high-risk condition predisposing them to Alzheimer's disease. ... Baltimore monitored nearly 5000 elderly residents of Cache County in ...
... lymphatic leukemia and dementia, was a regular with a day unit ... mentally decrepit clients. An ambulance team was in charge of picking ... at the residence. ,On August 20th 2003, the ambulance, ... door of an empty house of another patient, after a key ...
Cached Medicine News:Health News:Stress Can Cause Hair loss at 16 2Health News:Controversial Theory Says DNA Can Be Pushed To "Dark States" 2Health News:Controversial Theory Says DNA Can Be Pushed To "Dark States" 3Health News:Scientists Explain Complex Darwinian Evolution 2Health News:Competitive Advantage Are Attained In Which Freeloaders Are Punished 2Health News:Competitive Advantage Are Attained In Which Freeloaders Are Punished 3Health News:Competitive Advantage Are Attained In Which Freeloaders Are Punished 4
... The S7 gives enhanced deliverability ... Platform gives your short-wire capability and ... catheters. Secure Technology Stent Retention ... Discrete Technology designed to minimize balloon ...
The MULTI-LINK RX PENTA Coronary Stent Systems with new ACCESS-LINK Stent Design are indicated for improving coronary luminal diameter....
Now available in 2.75-mm diameters, the S660 small vessel coronary stent expands your treatment options for accurate sizing and precision stenting....
A fusion of first class deliverability, acute angiographic results and excellent versatility....
Medicine Products: